FDA investigating report of rare, serious brain infection in MS patient after taking Gilenya (fingolimod)

Posted
by Charles Miller

The FDA has issued a public safety alert after a patient in Europe diagnosed with possible multiple sclerosis (MS) reportedly developed a rare and serious brain infection known as progressive multifocal leukoencephalopathy (PML) after taking the drug Gilenya (fingolimod).

Gilenya is used to treat relapsing forms of MS, a nervous system disease that affects the brain and spinal cord. According to Novartis, the drug’s manufacturer, about 71,000 patients worldwide have been treated with Gilenya.

PML is a rare and serious brain infection caused by the John Cunningham virus that damages the fatty covering of the brain called myelin. PML can cause death or severe disability. The death rate has recently been reported to be about 20%. PML was first noted in patients receiving cancer chemotherapy and later in those infected with HIV.

The patient in question had been on fingolimod for nearly 8 months when PML was diagnosed, according to the Food and Drug Administration. The agency stopped short of saying fingolimod caused the condition. The FDA is working with Novartis to obtain and review all available information about the occurrence.

The FDA reports that this is the first case reported following the administration of Gilenya to a patient who had not previously received Tysabri (natalizumab), an MS drug associated with a higher risk of PML. A series of PML cases seen with natalizumab after the drug was first approved in 2004 led to its temporary removal from the market.

HO&P Fighting Big Pharma

The lawyers at Heygood, Orr & Pearson have made it a career priority to hold drug manufacturers accountable and responsible for their actions. As a result, we have spent years holding drug companies and medical device manufacturers responsible for the injuries and deaths caused by their reckless conduct. We have represented hundreds of people regarding dangerous fentanyl pain patches, defective hip and knee implant devices, Yaz, Actos, Avandia and Accutane—to name just some examples.

Heygood, Orr & Pearson is AV-rated, the highest legal and ethical rating available from the leading law firm rating service. Our partners Michael Heygood, Jim Orr, and Eric Pearson are all Board Certified in Personal Injury Trial Law by the Texas Board of Legal Specialization. Mr. Heygood and Mr. Orr are additionally Board Certified in Civil Trial Advocacy Law by the National Board of Trial Advocacy. Our partners been voted by their peers as “Super Lawyers” in the state of Texas for several years in a row.*

At Heygood, Orr & Pearson, we believe that when a drug company sells a drug or medical device that is dangerous and unsafe, they should be held responsible for the damage. We have the resources and experience to protect a person’s rights and the rights of their loved ones against irresponsible pharmaceutical companies and medical device manufacturers.

If you have been injured or have lost someone you care about because of defective or dangerous prescription drugs or medical devices, you deserve to have the manufacturer held responsible and to receive proper compensation. Contact us for a free consultation by calling toll-free at 1-877-446-9001 or by filling out the free consultation form on this page to find out more about your legal options.

———————————————————————————————————————————-

Michael Heygood, James Craig Orr, Jr. and Eric Pearson were selected to the Super Lawyers List, a Thomson Reuters publication, for the years 2003 through 2013.